Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Timeline

Start

2018-07-09

Primary completion

2019-12-27

Completion

2019-12-27

Outcome

Missed primary endpoint

release “The EPIONE study did not meet its primary endpoint in reduction of pruritus across the overall study population.” vandapharma.com ↗

Drugs

Indications